| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071758 CEACAM1 Based Cancer Therapy and Diagnosis |
| 03/29/2007 | US20070071757 detecting and diagnosing cancer or the likelihood of developing cancer based on the presence or absence of expression of PRDM11 or TBX21 or proteins encoded by those genes |
| 03/29/2007 | US20070071756 Delivery of an agent to ameliorate inflammation |
| 03/29/2007 | US20070071753 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 85 (gpr85) |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071741 OCL-2A3 compositions and uses thereof |
| 03/29/2007 | US20070071736 Propagating stem cells in growth factor mixture at preferential site in heart; tissue engineering; regenerative medicine |
| 03/29/2007 | US20070071735 Propagating stem cells in growth factor mixture at preferential site in heart; tissue engineering; regenerative medicine |
| 03/29/2007 | US20070071734 ARPE-19 as platform cell line for encapsulated cell-based delivery |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | US20070071726 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 03/29/2007 | US20070071725 Nitric oxide synthase gene transfer |
| 03/29/2007 | US20070071724 Methods for increasing learning and memory in amyloid-beta-related neurodegenerative disorders by increasing Uch-L1 activity and methods for identifying enhancers of Uch-L1 activity |
| 03/29/2007 | US20070071723 In Vivo Enhancement of Immune System Recognition of Neoplasms Following Treatment with an Oncolytic Virus or Gene Therapy Vector |
| 03/29/2007 | US20070071722 Nucleotide vaccine composition |
| 03/29/2007 | US20070071717 Treatment of B cells with IL-21 and B cell activators induces Granzyme B production |
| 03/29/2007 | US20070071690 Dry powder formulations |
| 03/29/2007 | US20070071683 Ultrasonic concentration of carrier particles |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
| 03/29/2007 | DE102005046490A1 New nucleic acid molecule comprising promoter, a transcriptable nucleic acid sequence, a first and second nucleic acid sequence for producing modified RNA with transcriptional stability and translational efficiency |
| 03/29/2007 | CA2623424A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/29/2007 | CA2623153A1 The use of sirnas in organ storage/reperfusion solutions |
| 03/28/2007 | EP1767655A1 Method of controlling cell functions |
| 03/28/2007 | EP1767650A1 Method of screening compound directly activating glycogen synthase |
| 03/28/2007 | EP1767643A1 Host cells and methods for the cytoprotection from oxidative and nitrosative stress |
| 03/28/2007 | EP1767642A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 03/28/2007 | EP1767641A1 Antigenic neisserial peptides |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |
| 03/28/2007 | EP1766082A2 Cog47 protein and s100beta gene polymorphism |
| 03/28/2007 | EP1766077A2 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
| 03/28/2007 | EP1766073A1 Enhancing protein expression |
| 03/28/2007 | EP1766071A2 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 03/28/2007 | EP1766063A2 Methods and kits to detect hereditary angioedema type iii |
| 03/28/2007 | EP1766053A2 Rna-containing microvesicles and methods therefor |
| 03/28/2007 | EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 03/28/2007 | EP1766035A1 Lipid encapsulated interfering rna |
| 03/28/2007 | EP1766025A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 03/28/2007 | EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 03/28/2007 | EP1766013A2 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 03/28/2007 | EP1766010A1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 03/28/2007 | EP1766009A2 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 03/28/2007 | EP1765989A2 Therapeutic delivery of adenosine into a tissue |
| 03/28/2007 | EP1765873A1 Methods and compositions using cd3 agonists |
| 03/28/2007 | EP1765847A2 Nuclease resistant double-stranded ribonucleic acid |
| 03/28/2007 | EP1765416A2 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 03/28/2007 | EP1765415A2 Oligomeric compounds that facilitate risc loading |
| 03/28/2007 | EP1765414A2 Peptide conjugated, inosine-substituted antisense oligomer compound and method |
| 03/28/2007 | EP1600510B1 DNA sequences having anti-repressor activity |
| 03/28/2007 | EP1403371B1 Polypeptide having a cell death inhibitory activity |
| 03/28/2007 | EP1363676B1 Method of enhancing delivery of a therapeutic nucleic acid |
| 03/28/2007 | EP1229933B1 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 03/28/2007 | EP1096936B1 Treatment of dyskinesia through mu selective opioid antagonists |
| 03/28/2007 | EP1082416B1 Poly(adp-ribose)polymerase gene |
| 03/28/2007 | EP0991426B2 Method for transferring nucleic acid into the striated muscle |
| 03/28/2007 | CN1938047A Methods of treating hemolytic anemia |
| 03/28/2007 | CN1936012A Method for coustructing shRNA expression carrier for inhibiting N-acetylglucosamine transferase V and its use |
| 03/28/2007 | CN1936011A Polycation lipesome telomere enzyme antiseuse oligonucleotide complex and preparation |
| 03/28/2007 | CN1936007A Anti H5N1 highly pathogenic avian influenza virus antisense oligonucleotide structure and its use |
| 03/28/2007 | CN1935999A Recombinant human esoderma colyone adenovirus, and its preparing method and use |
| 03/28/2007 | CN1935846A Fusion protein for treating diabetes, and its preparing method and use |
| 03/28/2007 | CN1935829A Nucleic acid hydrolysis cutting agent based on cucurbituril |
| 03/28/2007 | CN1935261A Medicine composition for preventing and treating diabetes mellitus and its use |
| 03/28/2007 | CN1935254A Neuregulin for treating cardio vascular disease, and its method and composition |
| 03/28/2007 | CN1307311C Carrier pcSH1-n capable of concurrently expressing multiple shRNA and its constructing method |
| 03/28/2007 | CN1307303C Methods and compositions based on VEGF antisense oligonucleotides |
| 03/28/2007 | CN1307300C Hematopoietic stem cells and methods of treatment neogenesis vascular ophthalmopathy |
| 03/28/2007 | CN1306965C Production of gene carrier and use thereof |
| 03/28/2007 | CN1306964C Decoy composition for treating and preventing inflammatory disease |
| 03/28/2007 | CN1306960C Curtail hemagglutinin vaccine for preventing influenza virus and its preparing method |
| 03/27/2007 | US7196192 28-epirapalogs |
| 03/27/2007 | US7196170 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 03/27/2007 | US7196070 Contacting, by ductal cannulation, the ductal epithelium of the exocrine gland with a cytolytic virus to destroy less than all of the ductal epithelium so as to inhibit formation of cancer of ductal epithelial origin |
| 03/27/2007 | US7196068 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 03/27/2007 | US7196067 Which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells; gene expression inhibition |
| 03/27/2007 | US7196062 Caldesmon, a protein found in smooth muscle and non-muscle cells, causes secondary degeneration of the actin-microfilament network and thereby interferes with actomyosin contractility and with formation of focal cell adhesions; reducing eye pressure |
| 03/27/2007 | US7195916 Method for expression of small antiviral RNA molecules within a cell |
| 03/27/2007 | US7195911 Mammalian cells that have increased proliferative capacity |
| 03/27/2007 | US7195910 Central nervous system disorders; antidiabetic agents |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195896 Complementary adenoviral vector systems and cell lines |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195867 Method for detection of multiple test materials in a sample |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2141555C Morphogenic protein soluble complex and composition thereof |
| 03/22/2007 | WO2007033353A2 Chemical target-binding compositions |
| 03/22/2007 | WO2007033215A2 Compositions having antiangiogenic activity and uses thereof |
| 03/22/2007 | WO2007033063A2 Regulation of the hedgehog signaling pathway and uses thereof |
| 03/22/2007 | WO2007033058A2 Compositions and methods for regulating rna translation via cd154 ca-dinucleotide repeat |
| 03/22/2007 | WO2007033023A2 Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |